Our endeavour is to demonstrate how we utilise novel advanced imaging with specific artificial intelligence tools (AI-ART doctoral training programme) and biomechanical-engineering to address mechanistic disease questions. To this end we will set up various platforms within our Consortium with the already established precision medicine networks. 

It is by utilising advanced spectroscopy, both light and electron microscopy quantitative imaging, as well as medical imaging that we can create a quantifiable spatio-temporal landscape related to underpinning the mechanisms in the dysregulation of molecular signalling.